Synthesis and pharmacological evaluation of pomalidomide derivatives useful for sickle cell disease treatment-Reference-Cited by-同舟云学术

Synthesis and pharmacological evaluation of pomalidomide derivatives useful for sickle cell disease treatment

Published:2021-09 Issue: Volume:114 Page:105077
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

de Melo Thais Regina Ferreira,Dulmovits Brian M.,Fernandes Guilherme Felipe dos Santos,de Souza Cristiane M.,Lanaro Carolina,He Minghzu,Al Abed Yousef,Chung Man Chin,Blanc Lionel,Costa Fernando Ferreira,dos Santos Jean Leandro

Funder

National Institutes of Health

Fundação de Amparo à Pesquisa do Estado de São Paulo

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference58 articles.

1. Sickle cell disease;Kato;Nat. Rev. Dis. Prim.,2018

2. Advances in Sickle Cell Disease Treatments;Pavan,2021

3. Fetal haemoglobin induction in sickle cell disease;Paikari;Br. J. Haematol.,2018

4. Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells;Parseval;J. Clin. Invest.,2008

5. Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice;Meiler;Blood,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro and In vivo Activity of a New N-Oxide Derivative for Acne Vulgaris Treatment;Medicinal Chemistry;2024-07-30

2. Red Blood Cells as Therapeutic Target to Treat Sickle Cell Disease;Antioxidants & Redox Signaling;2024-01-23

3. Phthalimide as a versatile pharmacophore scaffold: Unlocking its diverse biological activities;Drug Development Research;2023-07-26

4. The state of the art of fetal hemoglobin-inducing agents;Expert Opinion on Drug Discovery;2022-11-02

5. Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective;Pharmaceuticals;2022-06-16